Literature DB >> 33064158

[Evidence for robotics in oncological pancreatic surgery].

Yakup Kulu1, Markus W Büchler1, Thilo Hackert2.   

Abstract

Robotic surgical procedures have been implemented and have become an important development in pancreatic surgery with an increasing acceptance worldwide. Nearly all types of pancreatic surgery have now been performed robotically and especially standardized resections, such as distal pancreatectomy (RDP) and partial pancreatoduodenectomy (RPD) have gained importance despite a potentially long learning curve and high associated procedural costs. The present review article summarizes the available literature and evidence on the respective procedures focused on their use for indications of malignancy.

Entities:  

Keywords:  Distal pancreatectomy; Malignancy indications; Pancreatic cancer; Partial pancreatoduodenectomy; Robotic surgery

Year:  2021        PMID: 33064158     DOI: 10.1007/s00104-020-01299-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  3 in total

1.  A comparison between robotic-assisted laparoscopic distal pancreatectomy versus laparoscopic distal pancreatectomy.

Authors:  Brian K P Goh; Chung Yip Chan; Hui-Ling Soh; Ser Yee Lee; Peng-Chung Cheow; Pierce K H Chow; London L P J Ooi; Alexander Y F Chung
Journal:  Int J Med Robot       Date:  2016-01-27       Impact factor: 2.547

2.  Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer.

Authors:  Ibrahim Nassour; Samer Tohme; Richard Hoehn; Mohamed Abdelgadir Adam; Amer H Zureikat; Paniccia Alessandro
Journal:  Surg Endosc       Date:  2020-05-21       Impact factor: 4.584

3.  500 Minimally Invasive Robotic Pancreatoduodenectomies: One Decade of Optimizing Performance.

Authors:  Amer H Zureikat; Joal D Beane; Mazen S Zenati; Amr I Al Abbas; Brian A Boone; A James Moser; David L Bartlett; Melissa E Hogg; Herbert J Zeh
Journal:  Ann Surg       Date:  2021-05-01       Impact factor: 13.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.